The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Revasol Tussin DM Max with Honey
Dextromethorphan HBr and Guaifenesin · GUAIFENESIN 400 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL · Liquid · Oral · Rnv LLC
NDC 84379-0274-04 · 118 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for dextromethorphan hbr, guaifenesin (other) in the next 90 days
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Dextromethorphan HBr and Guaifenesin (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AARNA USA, Inc. | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mL | Jul 15, 2026 | Sep 3, 2026 |
| Meijer Distribution Inc | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Pharmadel LLC | GUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Raritan Pharmaceuticals | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 200 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Rnv LLC | GUAIFENESIN 400 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL | Aug 26, 2026 | Sep 2, 2026 |
| The Procter & Gamble Manufacturing Company | DEXTROMETHORPHAN HYDROBROMIDE 5 mg/7.5mL; GUAIFENESIN 100 mg/7.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates, LLC | DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mL; GUAIFENESIN 100 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Pharmadel LLC | GUAIFENESIN 5 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 100 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Rnv LLC | GUAIFENESIN 20 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 400 mg/20mL | Jul 22, 2026 | Aug 19, 2026 |
| Pharmadel LLC | DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mL; GUAIFENESIN 100 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
| Rnv LLC | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 400 mg/20mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Revasol Tussin DM Max with Honey — NDC 84379-0274-04," retrieved September 3, 2026, https://drugdashboards.com/drug/84379027404.
Free to cite with attribution — see how the data is put together.